IL
Illinois House Bill HB3180

Illinois 2023-2024 Regular Session

Illinois House Bill HB3180 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB3180 Introduced , by Rep. Tom Weber SYNOPSIS AS INTRODUCED: 720 ILCS 570/210 from Ch. 56 1/2, par. 1210 Amends the Illinois Controlled Substances Act. Adds Clonazolam as a Schedule IV controlled substance. LRB103 29935 RLC 56350 b A BILL FOR 103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB3180 Introduced , by Rep. Tom Weber SYNOPSIS AS INTRODUCED: 720 ILCS 570/210 from Ch. 56 1/2, par. 1210 720 ILCS 570/210 from Ch. 56 1/2, par. 1210 Amends the Illinois Controlled Substances Act. Adds Clonazolam as a Schedule IV controlled substance. LRB103 29935 RLC 56350 b LRB103 29935 RLC 56350 b A BILL FOR
22 103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB3180 Introduced , by Rep. Tom Weber SYNOPSIS AS INTRODUCED:
33 720 ILCS 570/210 from Ch. 56 1/2, par. 1210 720 ILCS 570/210 from Ch. 56 1/2, par. 1210
44 720 ILCS 570/210 from Ch. 56 1/2, par. 1210
55 Amends the Illinois Controlled Substances Act. Adds Clonazolam as a Schedule IV controlled substance.
66 LRB103 29935 RLC 56350 b LRB103 29935 RLC 56350 b
77 LRB103 29935 RLC 56350 b
88 A BILL FOR
99 HB3180LRB103 29935 RLC 56350 b HB3180 LRB103 29935 RLC 56350 b
1010 HB3180 LRB103 29935 RLC 56350 b
1111 1 AN ACT concerning criminal law.
1212 2 Be it enacted by the People of the State of Illinois,
1313 3 represented in the General Assembly:
1414 4 Section 5. The Illinois Controlled Substances Act is
1515 5 amended by changing Section 210 as follows:
1616 6 (720 ILCS 570/210) (from Ch. 56 1/2, par. 1210)
1717 7 Sec. 210. (a) The controlled substances listed in this
1818 8 Section are included in Schedule IV.
1919 9 (b) Unless specifically excepted or unless listed in
2020 10 another schedule, any material, compound, mixture, or
2121 11 preparation containing limited quantities of any of the
2222 12 following narcotic drugs, or their salts calculated as the
2323 13 free anhydrous base or alkaloid, as set forth below:
2424 14 (1) Not more than 1 milligram of difenoxin (DEA Drug
2525 15 Code No. 9618) and not less than 25 micrograms of atropine
2626 16 sulfate per dosage unit.
2727 17 (2) Dextropropoxyphene (Alpha-(+)-4-dimethylamino-1,
2828 18 2-diphenyl-3-methyl-2-propionoxybutane).
2929 19 (c) Unless specifically excepted or unless listed in
3030 20 another schedule, any material, compound, mixture, or
3131 21 preparation which contains any quantity of the following
3232 22 substances having a potential for abuse associated with a
3333 23 depressant effect on the central nervous system:
3434
3535
3636
3737 103RD GENERAL ASSEMBLY State of Illinois 2023 and 2024 HB3180 Introduced , by Rep. Tom Weber SYNOPSIS AS INTRODUCED:
3838 720 ILCS 570/210 from Ch. 56 1/2, par. 1210 720 ILCS 570/210 from Ch. 56 1/2, par. 1210
3939 720 ILCS 570/210 from Ch. 56 1/2, par. 1210
4040 Amends the Illinois Controlled Substances Act. Adds Clonazolam as a Schedule IV controlled substance.
4141 LRB103 29935 RLC 56350 b LRB103 29935 RLC 56350 b
4242 LRB103 29935 RLC 56350 b
4343 A BILL FOR
4444
4545
4646
4747
4848
4949 720 ILCS 570/210 from Ch. 56 1/2, par. 1210
5050
5151
5252
5353 LRB103 29935 RLC 56350 b
5454
5555
5656
5757
5858
5959
6060
6161
6262
6363 HB3180 LRB103 29935 RLC 56350 b
6464
6565
6666 HB3180- 2 -LRB103 29935 RLC 56350 b HB3180 - 2 - LRB103 29935 RLC 56350 b
6767 HB3180 - 2 - LRB103 29935 RLC 56350 b
6868 1 (1) Alprazolam;
6969 2 (2) Barbital;
7070 3 (2.1) Bromazepam;
7171 4 (2.2) Camazepam;
7272 5 (2.3) Carisoprodol;
7373 6 (3) Chloral Betaine;
7474 7 (4) Chloral Hydrate;
7575 8 (5) Chlordiazepoxide;
7676 9 (5.1) Clobazam;
7777 10 (6) Clonazepam;
7878 11 (6.1) Clonazolam;
7979 12 (7) Clorazepate;
8080 13 (7.1) Clotiazepam;
8181 14 (7.2) Cloxazolam;
8282 15 (7.3) Delorazepam;
8383 16 (8) Diazepam;
8484 17 (8.05) Dichloralphenazone;
8585 18 (8.1) Estazolam;
8686 19 (9) Ethchlorvynol;
8787 20 (10) Ethinamate;
8888 21 (10.1) Ethyl loflazepate;
8989 22 (10.2) Fludiazepam;
9090 23 (10.3) Flunitrazepam;
9191 24 (11) Flurazepam;
9292 25 (11.1) Fospropofol;
9393 26 (12) Halazepam;
9494
9595
9696
9797
9898
9999 HB3180 - 2 - LRB103 29935 RLC 56350 b
100100
101101
102102 HB3180- 3 -LRB103 29935 RLC 56350 b HB3180 - 3 - LRB103 29935 RLC 56350 b
103103 HB3180 - 3 - LRB103 29935 RLC 56350 b
104104 1 (12.1) Haloxazolam;
105105 2 (12.2) Ketazolam;
106106 3 (12.3) Loprazolam;
107107 4 (13) Lorazepam;
108108 5 (13.1) Lormetazepam;
109109 6 (14) Mebutamate;
110110 7 (14.1) Medazepam;
111111 8 (15) Meprobamate;
112112 9 (16) Methohexital;
113113 10 (17) Methylphenobarbital (Mephobarbital);
114114 11 (17.1) Midazolam;
115115 12 (17.2) Nimetazepam;
116116 13 (17.3) Nitrazepam;
117117 14 (17.4) Nordiazepam;
118118 15 (18) Oxazepam;
119119 16 (18.1) Oxazolam;
120120 17 (19) Paraldehyde;
121121 18 (20) Petrichloral;
122122 19 (21) Phenobarbital;
123123 20 (21.1) Pinazepam;
124124 21 (22) Prazepam;
125125 22 (22.1) Quazepam;
126126 23 (23) Temazepam;
127127 24 (23.1) Tetrazepam;
128128 25 (23.2) Tramadol;
129129 26 (24) Triazolam;
130130
131131
132132
133133
134134
135135 HB3180 - 3 - LRB103 29935 RLC 56350 b
136136
137137
138138 HB3180- 4 -LRB103 29935 RLC 56350 b HB3180 - 4 - LRB103 29935 RLC 56350 b
139139 HB3180 - 4 - LRB103 29935 RLC 56350 b
140140 1 (24.5) Zaleplon;
141141 2 (25) Zolpidem;
142142 3 (26) Zopiclone.
143143 4 (d) Any material, compound, mixture, or preparation which
144144 5 contains any quantity of the following substances, including
145145 6 its salts, isomers (whether optical, position, or geometric),
146146 7 and salts of such isomers, whenever the existence of such
147147 8 salts, isomers and salts of isomers is possible:
148148 9 (1) Fenfluramine.
149149 10 (e) Unless specifically excepted or unless listed in
150150 11 another schedule any material, compound, mixture, or
151151 12 preparation which contains any quantity of the following
152152 13 substances having a stimulant effect on the central nervous
153153 14 system, including its salts, isomers (whether optical,
154154 15 position or geometric), and salts of such isomers whenever the
155155 16 existence of such salts, isomers, and salts of isomers is
156156 17 possible within the specific chemical designation:
157157 18 (1) Cathine ((+)-norpseudoephedrine);
158158 19 (1.1) Diethylpropion;
159159 20 (1.2) Fencamfamin;
160160 21 (1.3) Fenproporex;
161161 22 (2) Mazindol;
162162 23 (2.1) Mefenorex;
163163 24 (3) Phentermine;
164164 25 (4) Pemoline (including organometallic complexes and
165165 26 chelates thereof);
166166
167167
168168
169169
170170
171171 HB3180 - 4 - LRB103 29935 RLC 56350 b
172172
173173
174174 HB3180- 5 -LRB103 29935 RLC 56350 b HB3180 - 5 - LRB103 29935 RLC 56350 b
175175 HB3180 - 5 - LRB103 29935 RLC 56350 b
176176 1 (5) Pipradrol;
177177 2 (6) SPA ((-)-1-dimethylamino-1, 2-diphenylethane);
178178 3 (7) Modafinil;
179179 4 (8) Sibutramine.
180180 5 (f) Other Substances. Unless specifically excepted or
181181 6 unless listed in another schedule, any material, compound,
182182 7 mixture, or preparation that contains any quantity of the
183183 8 following substance, including its salts:
184184 9 (1) Butorphanol (including its optical isomers).
185185 10 (g) The Department may except by rule any compound,
186186 11 mixture, or preparation containing any depressant substance
187187 12 listed in subsection (b) from the application of all or any
188188 13 part of this Act if the compound, mixture, or preparation
189189 14 contains one or more active medicinal ingredients not having a
190190 15 depressant effect on the central nervous system, and if the
191191 16 admixtures are included therein in combinations, quantity,
192192 17 proportion, or concentration that vitiate the potential for
193193 18 abuse of the substances which have a depressant effect on the
194194 19 central nervous system.
195195 20 (h) Except as otherwise provided in Section 216, any
196196 21 material, compound, mixture, or preparation that contains any
197197 22 quantity of the following substance having a stimulant effect
198198 23 on the central nervous system, including its salts,
199199 24 enantiomers (optical isomers) and salts of enantiomers
200200 25 (optical isomers):
201201 26 (1) Ephedrine, its salts, optical isomers and salts of
202202
203203
204204
205205
206206
207207 HB3180 - 5 - LRB103 29935 RLC 56350 b
208208
209209
210210 HB3180- 6 -LRB103 29935 RLC 56350 b HB3180 - 6 - LRB103 29935 RLC 56350 b
211211 HB3180 - 6 - LRB103 29935 RLC 56350 b
212212 1 optical isomers.
213213 2 (Source: P.A. 97-334, eff. 1-1-12.)
214214
215215
216216
217217
218218
219219 HB3180 - 6 - LRB103 29935 RLC 56350 b